Prophylactic Antibiotics or Placebo After Hypospadias Repair
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hypospadias
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Prevention
Participation Requirements
- Age
- Younger than 5 years
- Gender
- Only males
Description
Participants in this multicenter, double-blind study are randomized to receive trimethoprim-sulfamethoxazole or placebo for 10 days postoperatively. Short- and intermediate-term results will be published after participants complete 6 months and 5 years of follow-up, respectively.
Participants in this multicenter, double-blind study are randomized to receive trimethoprim-sulfamethoxazole or placebo for 10 days postoperatively. Short- and intermediate-term results will be published after participants complete 6 months and 5 years of follow-up, respectively.
Tracking Information
- NCT #
- NCT02096159
- Collaborators
- The Hospital for Sick Children
- Investigators
- Principal Investigator: Earl Y Cheng, MD Ann & Robert H Lurie Children's Hospital of Chicago Principal Investigator: Mark A Faasse, MD, MPH Ann & Robert H Lurie Children's Hospital of Chicago